11 Jun 2014
In a new study presented at the European League Against Rheumatism Annual Congress, scientists have shown that romosozumab caused an increase in bone mineral density and bone content in postmenopausal women with low bone mass.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024